Feasibility and safety of enzymatic debridement for the prevention of operative escharotomy in circumferential deep burns of the distal upper extremity - ScienceDirect
Limitations to the use of bromelain-based enzymatic debridement (NexoBrid®) for treating diabetic foot burns: a case series of disappointing results - Juan Enrique Berner, Dejan Keckes, Matthew Pywell, Baljit Dheansa, 2018
Experiences of Bromelain-Based Enzymatic Debridement (Nexobrid) in Burn Patients: A Clinical Report
Nexobrid: Package Insert / Prescribing Information - Drugs.com
Microbial profile of burn wounds managed with enzymatic debridement using bromelain-based agent, NexoBrid® - ScienceDirect
Use of a selective enzymatic debridement agent (Nexobrid®) for wound management: Learning curve
EBJ | Free Full-Text | The Use of Intact Fish Skin as a Novel Treatment Method for Deep Dermal Burns Following Enzymatic Debridement: A Retrospective Case-Control Study
Severe Burn Therapy NexoBrid Gets FDA Approval - MPR
NexoBrid; Common name: Concentrate of proteolytic enzymes enriched in bromelain
Experiences of Bromelain-Based Enzymatic Debridement (Nexobrid) in Burn Patients: A Clinical Report
Bromelain-based enzymatic debridement and minimal invasive modality (mim) care of deeply burned hands. - Abstract - Europe PMC
Medical Science Monitor | Evaluation of Bromelain-Based Enzymatic Debridement Combined with Laser Doppler Imaging and Healing of Burn Wounds - Article abstract #936713
Use of a selective enzymatic debridement agent (Nexobrid®) for wound management: Learning curve
g596015.jpg
ANALYST AND INVESTOR DAY
NEXOBRID® NORTH AMERICAN LICENSE AGREEMENT SUMMARY
Economic Spillovers From Public Investments in Medical Countermeasures: A Case Study of a Burn Debridement Product | Disaster Medicine and Public Health Preparedness | Cambridge Core
Experiences of Bromelain-Based Enzymatic Debridement (Nexobrid) in Burn Patients: A Clinical Report
State of the art in enzymatic debridement
Nexobrid: Package Insert / Prescribing Information - Drugs.com
Frontiers | Advancements in Regenerative Strategies Through the Continuum of Burn Care
PDF) Use of a selective enzymatic debridement agent (Nexobrid®) for wound management: Learning curve
Successful treatment of mixed depth flame burns using enzymatic debridement with Nexobrid™ in a patient with aggressive systemic sclerosis (scleroderma) - Neil Wickham, K. Skaria Alexander, Anthony Fletcher, Ciaran O'Boyle, 2019
Limitations to the use of bromelain-based enzymatic debridement (NexoBrid®) for treating diabetic foot burns: a case series of disappointing results - Juan Enrique Berner, Dejan Keckes, Matthew Pywell, Baljit Dheansa, 2018
